VCI Global Secures Its First IPO Consultancy Deal In 2024 With A Singapore-Based Fin-MedTech Medical Group; IPO On Nasdaq Is Expected To Be Completed In 2024/2025
Portfolio Pulse from Benzinga Newsdesk
VCI Global Limited (NASDAQ:VCIG) has secured a consultancy deal with a Singapore-based Fin-MedTech Medical Group for its upcoming IPO on Nasdaq, expected to be completed in 2024/2025. VCI Global will provide services including equity structure, capital market strategy, and regulatory approval assistance. The company will be compensated in shares, with estimated income from the deal between USD 4 million to USD 8 million.
January 23, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
VCI Global Limited has been engaged as an IPO consultant for a Singapore-based Fin-MedTech Medical Group's Nasdaq IPO, with an estimated income of $4-8M in shares.
The news of securing a significant IPO consultancy deal is likely to be viewed positively by investors, as it not only enhances VCI Global's reputation in the IPO consultancy space but also promises a substantial income in shares. The deal indicates potential growth and expansion of VCI Global's business operations, which could positively influence the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100